Global Digital X-ray Market - Global Forecast to 2027

The global digital X-ray market is predicted to grow at an annual rate of 8.1 percent from 2021 to 2027, from an estimated USD 11.1 billion in 2027. The growing elderly population and increase in disease incidence, as well as favourable government laws, investments, and initiatives, are all driving this industry forward. The benefits of digital X-ray equipment have aided their acceptance; their speed and accuracy, as well as rapid processing times, allow for substantially higher patient screening numbers than previously possible. Companies have been compelled to focus on product development and innovation as a result of this. However, these systems are expensive, delaying their widespread implementation. Other concerns such as diminishing reimbursements, a lack of infrastructure, especially in emerging and undeveloped nations, and the possible hazards connected with radiation exposure are projected to stymie the market's expansion.

Impact of COVID-19 on the global digital X-ray market

In 2020, the COVID-19 pandemic had a negative impact on the economy and posed numerous obstacles to clinical healthcare practitioners and patients all across the world. COVID-19 has also had an impact on numerous levels of the value chain, owing to the stringent lockdowns imposed by most governments. Due to modern packaging rules and country-imposed lockout procedures, the turnaround time for product and service delivery has also been impacted. All of these variables have a negative impact on digital X-ray system manufacturing and supply chains.

COVID-19, on the other hand, has opened up new possibilities for digital X-ray makers and healthcare providers. Chest imaging has been explored as an alternate option for individuals with suspected or probable COVID-19 in situations when laboratory testing (RT-PCR) is not available, or results are delayed or initially negative.

Imaging tests such as chest radiography, CT scans, and lung ultrasounds have been used to supplement clinical evaluation and laboratory data in the management of COVID-19 patients. Chest radiography, according to the WHO, can aid in the dynamic evaluation of COVID-19 pneumonia and associated consequences. On a bedside chest radiograph, the resolution or development of lung consolidation can aid caregivers in making better therapeutic management decisions. The management of a pneumothorax or pneumomediastinum might also be aided by chest imaging.